Search clinical trials for: AZD9977, oral solution

Total 26905 results

Jazz Pharmaceuticals

Completed

A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension

Idiopathic Hypersomnia

France, Spain, United States, Belgium, United Kingdom, Poland, Czechia, Finland
Galapagos NV

Completed

A Study to Assess Relative Bioavailability of and Effect of Food on a New Oral Tablet Formulation of GLPG3970

Healthy

France
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...
Morris Enterprise Co.,Ltd.

Enrolling by invitation

Double-Blind, Placebo-Controlled Trial of Eefooton in Patients With Chronic Kidney Disease

Urologic Diseases | Chronic Kidney Diseases | Renal Insufficiency, Chronic

Taiwan
Radius Pharmaceuticals, Inc.

Terminated

Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Childhood Absence Epilepsy

United States
AstraZeneca
Quotient Sciences

Completed

A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831

Cardiovascular Disease

United Kingdom
INSYS Therapeutics Inc

Terminated

Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms

Spasms, Infantile

United States
Richever Enterprise Co., Ltd.

Unknown

Clinical Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution®)

Galactose Single Point (GSP), Residual Liver Function
TorreyPines Therapeutics

Completed

A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers

Healthy | Hyperalgesia

United States
Basilea Pharmaceutica

Completed

A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males

Fungal Infection

United Kingdom
Meyer Children's Hospital IRCCS

Not yet recruiting

Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy (CBD_RE)

Epilepsy | Rare Diseases
AstraZeneca
Quotient Sciences

Completed

A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833

ER-positive, HER2-negative Breast Cancer

United Kingdom
Norgine
Quotient Sciences

Completed

A Pharmacokinetic Study of PLENVU® in Healthy Subjects (PKPU)

Pharmacokinetic

United Kingdom
Radius Pharmaceuticals, Inc.
Benuvia Therapeutics Inc.

Terminated

A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
INSYS Therapeutics Inc

Completed

Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

Seizures

United States
Anthera Pharmaceuticals

Completed

SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis (SIMPLICITY)

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
INSYS Therapeutics Inc

Completed

Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders

Seizures

United States
Aquinox Pharmaceuticals (Canada) Inc.
Quotient Clinical

Completed

Phase 1 Absorption Distribution Metabolism and Excretion of AQX-1125 (ADME)

Healthy Volunteer

United Kingdom
Abbott Nutrition

Recruiting

Oral Rehydration Solutions in Healthy Adult Athletes

Hydration

United States
MultiCare Health System Research Institute

No longer available

Expanded Use of Cannabidiol Oral Solution

Refractory Epilepsy
Radius Pharmaceuticals, Inc.
Benuvia Therapeutics Inc.

Terminated

Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Childhood Absence Epilepsy

United States
AstraZeneca

Completed

A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients

Carcinoma | Cancer | Tumors

Japan
Swedish Herbal Institute AB
Tbilisi State Medical University; Phytomed AB; National Family Medicine Training...

Completed

Efficacy of Adaptogens in Patients With Long COVID-19

Covid19

Georgia
Boehringer Ingelheim

Completed

Investigation of the Metabolism and Pharmacokinetics of Ambroxol in Healthy Male Volunteers

Healthy
Bayer

Completed

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Neoplasms

France, United States, Spain, Singapore, Germany, Korea, Republic of, Switzerland
New York Medical College
National Institute of Neurological Disorders and Stroke (NINDS); National Institutes...

Active, not recruiting

Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients

Chronic Fatigue Syndrome | Postural Tachycardia Syndrome (POTS) | Myalgic Encephalomyelitis | Systemic Exertion Intolerance Disease (SEID) | Neurally Mediated Syncope (NMS)

United States
Biogen

Completed

Study Of The PF-04958242 Blood Concentrations Of A Capsule Formulation Of PF-04958242 Compared To A Solution Formulation

Healthy

United States
Takeda

Completed

A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants

Healthy Volunteers

United States
Takeda

Completed

A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants

Healthy Volunteers

United States
Indonesia University

Recruiting

The Effects of Carbohydrate-electrolyte Solution on Metabolic Responses in Paediatric Patients

Fasting

Indonesia
Lianyungang Kanion Group, Ltd.

Completed

JINZHEN for Treatment of Mild to Moderate COVID-19

COVID-19

United States
Silkiss Eye Surgery
Jazz Pharmaceuticals; Smith-Kettlewell Eye Research Institute; Benign Essential...

Completed

Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm

CBD | Blepharospasm | Blepharospasm, Benign Essential

United States
Pfizer

Completed

A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis

Plaque Psoriasis

United States
Galapagos NV
PRA Health Sciences

Completed

Bioavailability Study With GLPG1972

Osteoarthritis

Netherlands
Medical University of South Carolina

Recruiting

SCORE Emerging Adult Cannabis Use & Stress

Cannabis Use Disorder

United States
University of California, San Diego
Center for Medicinal Cannabis Research

Recruiting

Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

Early Psychosis

United States
QOL Medical, LLC

Completed

Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance

Fructan Intolerance

United States
SupremeCure Pharma Inc.

Withdrawn

Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors

Refractory Solid Tumor
Seoul National University Hospital
Seoul National University Bundang Hospital

Terminated

Evaluation of Preoperative Oral Rehydration Solution in Colectomy

Insulin Resistance | Postoperative Complication

Korea, Republic of
Meriyana Bio Inc.
US Oncology Research

Terminated

Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue

Fatigue | Metastatic Breast Cancer
Taiho Oncology, Inc.

Completed

Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI

Advanced Solid Tumors (Excluding Breast Cancer)

United States
Millennium Pharmaceuticals, Inc.

Completed

Study to Assess Absolute Bioavailability (ABA) of TAK-906 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]-TAK-906 in Healthy Male Participants

Healthy Volunteers

United States
Children's & Women's Health Centre of British Columbia

Completed

Sweetheart Study: Oral Glucose for Reducing Stress During Echocardiographic Assessment in Infants in the NICU

Cardiac Echocardiography Assessment

Canada
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.

Healthy

Germany
AstraZeneca

Completed

A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients

Arrhythmia

Sweden, Norway
AstraZeneca

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male Volunteers

Healthy

Sweden
Catalysis SL

Not yet recruiting

Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

Sarcoma | Advanced Solid Tumor | Advanced Cancer | Pediatric Cancer | Lymphoma, Hodgkin | Central Nervous System Tumor | Germ Cell Tumor

Honduras
Université de Sherbrooke
Canadian Institutes of Health Research (CIHR); Centre de recherche du Centre... and other collaborators

Not yet recruiting

Effect of CBD on the Brain

Fragile X Syndrome
University of California, San Diego
Wholistic Research and Education Foundation

Active, not recruiting

Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism

Autism Spectrum Disorder | Autism

United States
VA Connecticut Healthcare System

Unknown

Polyethylene Glycol Cleansing in Patients at High Risk for Poor Bowel Preparation

Colonoscopy

United States
AstraZeneca

Terminated

Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis (DERMIS)

Plaque Psoriasis Vulgaris

Denmark

3

Subscribe